BHP Billiton Limited (ADR) (NYSE:BHP) turned in a strong set of results for the six months to end-December, boosting attributable profit 82.9% and increasing the dividend. But the market’s response could be summed up in a word: “boring”. BHP Billiton Limited (ADR) (NYSE:BHP) stock opened at $70.43 in last session, and closed at $70.33, while the day range of stock is $69.60 – $70.48. The stock showed a positive weekly performance of 7.60%.
Rio Tinto plc (ADR) (NYSE:RIO)‘s stock had its “outperform” rating reiterated by Credit Suisse in a research note issued on Wednesday, Analyst Ratings Net reports. They currently have a GBX 4,200 ($70.39) price objective on the stock. Rio Tinto plc (ADR) (NYSE:RIO) stock opened at $59.65, in last session and closed at $59.81, by gaining 1.54%. The 52 week range of the stock is $39.14 – $60.04. Company’s market capitalization is $110.57 billion.
Analysts at Jefferies Group hoisted their price objective on shares of BioMarin Pharmaceutical (NYSE:BMRN) from $83.00 to $87.00 in a research report issued to clients and investors on Wednesday, AnalystRatingsNetwork reports. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stock advanced 0.77% and finished the last session at $76.39. The EPS of the stock remained -1.27. Company’s market capitalization is $10.86 billion.
Mast Therapeutics Inc (NYSEMKT:MSTX) on Feb. 18 announced new data from its randomized, placebo-controlled, nonclinical study of MST-188 (low dose and high dose) in a model of chronic heart failure. The Company previously announced that a single, two-hour infusion of MST-188 improved left ventricular systolic function that was significant immediately (at the end of MST-188 administration) and remained significant at one week (and, in some cases, at two weeks) after MST-188 administration. Mast Therapeutics Inc (NYSEMKT:MSTX) stock opened the session at $0.86, and closed the session at $0.825. The 52 week range of the stock remained $0.40 – $1.10 and the day range was $0.82 – $0.88.